* Immunomedics Inc., of Morris Plains, N.J., receivedU.S. patent 5,443,953 related to imaging and treatmentswith immunoconjugates, such as antibodies and antibodyfragments, that have a unique carbohydrate attached as abinding site.* Mitotix Inc., of Cambridge, Mass., received U.S. patent5,443,962 for a series of cell-based assays for inhibitorsof human, fungal and protozoan cdc25 enzymes, whichregulate cell division. Another patent 5,441,880, issued toCold Spring Harbor Laboratory in New York andlicensed to Mitotix, covers human and recombinantversions of two cdc25 proteins.
(c) 1997 American Health Consultants. All rights reserved.